This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vile, R. G. Articles by Hart, I. R. Search for Related Content PubMed PubMed Citation Articles by Vile, R. G. Articles by Hart, I. R.

In Vitro and in Vivo Targeting of Gene Expression to Melanoma Cells

Biology of Metastasis Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom

Gene therapy protocols for cancer usually involve removal of tumor cells, culture in vitro to allow gene transfer, and subsequent reintroduction in vivo. Targeting therapeutic genes to tumor cells in situ requires an accuracy of gene delivery that currently is not possible with the use of existing techniques. To overcome these limitations we have used two promoters, which are preferentially active in melanocytic cells, to direct gene expression specifically to melanoma cells both in vitro and in vivo. Here we describe experiments showing that as little as 769 base pairs of the 5'-flanking regions of the tyrosinase, and 1.4 kilobase pair of the tyrosinase-related protein 1, genes are sufficient to direct expression of the ß-galactosidase gene to both human and murine melanoma cells and melanocytes, while not permitting expression in a range of other cell types in vitro. These promoters showed high levels of activity in 12 of 14 murine and human melanoma cell lines tested but showed only basal levels of activity, similar to that of a promoterless construct, in a range of 12 other cell types. Cell type specificity is maintained when the construct is delivered to cells either by physical means or by inclusion of the cell type-specific expression cassette into a retroviral vector. Direct injection of DNA, encoding the ß-galactosidase gene expressed from either promoter, into established B16 melanomas or Colo 26 tumors in syngenelc mice resulted in extensive transduction of tumor cells in the B16 melanomas (10% of tumor cells expressing 10 days after DNA injection), whereas no blue-staining cells were seen in the Colo 26 tumors. The reporter gene was expressed in melanoma cells and in some normal melanocytes but not in other surrounding normal tissue. We propose that the combination of a tissue-specific promoter driving a therapeutic gene, with delivery of such a construct directly to sites of tumor growth in vivo, either by direct DNA injection or by retroviral infection, may provide significantly enhanced safety for gene therapy for solid tumors.

Received 12/17/92. Accepted 1/20/93.

This article has been cited by other articles:

				L. Sanchez-Perez, T. Kottke, G. A. Daniels, R. M. Diaz, J. Thompson, J. Pulido, A. Melcher, and R. G. Vile Killing of Normal Melanocytes, Combined with Heat Shock Protein 70 and CD40L Expression, Cures Large Established Melanomas J. Immunol., September 15, 2006; 177(6): 4168 - 4177. [Abstract] [Full Text] [PDF]

				L. Sanchez-Perez, T. Kottke, R. M. Diaz, A. Ahmed, J. Thompson, H. Chong, A. Melcher, S. Holmen, G. Daniels, and R. G. Vile Potent Selection of Antigen Loss Variants of B16 Melanoma following Inflammatory Killing of Melanocytes In vivo Cancer Res., March 1, 2005; 65(5): 2009 - 2017. [Abstract] [Full Text] [PDF]

				L. Barzon, M. Boscaro, and G. Palu Endocrine Aspects of Cancer Gene Therapy Endocr. Rev., February 1, 2004; 25(1): 1 - 44. [Abstract] [Full Text] [PDF]

				D. M. Nettelbeck, A. A. Rivera, C. Balague, R. Alemany, and D. T. Curiel Novel Oncolytic Adenoviruses Targeted to Melanoma: Specific Viral Replication and Cytolysis by Expression of E1A Mutants from the Tyrosinase Enhancer/Promoter Cancer Res., August 15, 2002; 62(16): 4663 - 4670. [Abstract] [Full Text] [PDF]

				J. Gu, S. Kagawa, M. Takakura, S. Kyo, M. Inoue, J. A. Roth, and B. Fang Tumor-specific Transgene Expression from the Human Telomerase Reverse Transcriptase Promoter Enables Targeting of the Therapeutic Effects of the Bax Gene to Cancers Cancer Res., October 1, 2000; 60(19): 5359 - 5364. [Abstract] [Full Text]

				N. Koshikawa, K. Takenaga, M. Tagawa, and S. Sakiyama Therapeutic Efficacy of the Suicide Gene Driven by the Promoter of Vascular Endothelial Growth Factor Gene against Hypoxic Tumor Cells Cancer Res., June 1, 2000; 60(11): 2936 - 2941. [Abstract] [Full Text] [PDF]

				S. Todryk, A. A. Melcher, N. Hardwick, E. Linardakis, A. Bateman, M. P. Colombo, A. Stoppacciaro, and R. G. Vile Heat Shock Protein 70 Induced During Tumor Cell Killing Induces Th1 Cytokines and Targets Immature Dendritic Cell Precursors to Enhance Antigen Uptake J. Immunol., August 1, 1999; 163(3): 1398 - 1408. [Abstract] [Full Text] [PDF]

				G. Gazit, G. Hung, X. Chen, W. F. Anderson, and A. S. Lee Use of the Glucose Starvation-inducible Glucose-regulated Protein 78 Promoter in Suicide Gene Therapy of Murine Fibrosarcoma Cancer Res., July 1, 1999; 59(13): 3100 - 3106. [Abstract] [Full Text] [PDF]

				E. de Zoeten, V. Carr-Brendel, D. Markovic, J. Taylor-Papadimitriou, and E. P. Cohen Treatment of Breast Cancer with Fibroblasts Transfected with DNA from Breast Cancer Cells J. Immunol., June 1, 1999; 162(11): 6934 - 6941. [Abstract] [Full Text] [PDF]

				C. Spitzweg, S. Zhang, E. R. Bergert, M. R. Castro, B. McIver, A. E. Heufelder, D. J. Tindall, C. Y. F. Young, and J. C. Morris Prostate-specific Antigen (PSA) Promoter-driven Androgen-inducible Expression of Sodium Iodide Symporter in Prostate Cancer Cell Lines Cancer Res., May 1, 1999; 59(9): 2136 - 2141. [Abstract] [Full Text] [PDF]

				E. F. de Zoeten, V. Carr-Brendel, and E. P. Cohen Resistance to Melanoma in Mice Immunized with Semiallogeneic Fibroblasts Transfected with DNA from Mouse Melanoma Cells J. Immunol., March 15, 1998; 160(6): 2915 - 2922. [Abstract] [Full Text] [PDF]

				R. M. Diaz, T. Eisen, I. R. Hart, and R. G. Vile Exchange of Viral Promoter/Enhancer Elements with Heterologous Regulatory Sequences Generates Targeted Hybrid Long Terminal Repeat Vectors for Gene Therapy of Melanoma J. Virol., January 1, 1998; 72(1): 789 - 795. [Abstract] [Full Text] [PDF]

				R M Schmid, H Weidenbach, G F Draenert, S Liptay, H Luhrs, and G Adler Liposome mediated gene transfer into the rat oesophagus Gut, October 1, 1997; 41(4): 549 - 556. [Abstract] [Full Text] [PDF]